Home BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group
 

Keywords :   


BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group

2015-10-18 09:44:56| Biotech - Topix.net

The firm presently has a "hold" rating on the biotechnology company's stock. Jefferies Group's price objective would indicate a potential upside of 13.12% from the stock's previous close.

Tags: price group target lowered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »